To in-depth explore whether diosgenin exerts antitumor activity via modulation of Skp2 in breast cancer cells, we used Skp2 siRNA to reduce the Skp2 expression in breast cancer cells followed by diosgenin exposures for different times. This evidence concerns the gene SKP2 and breast cancer.